{
  "Q0": "Neuromuscular gene panel test",
  "Q1": "Not specified",
  "Q2": "No",
  "Q3": "No",
  "Q4": "No",
  "Q5": "No",
  "Q6": "No",
  "Q7": "No",
  "Q8": "Yes",
  "Q8.1": "Targeted testing after conventional diagnostic studies",
  "Q9": "Yes",
  "Q9.1": "No",
  "Q10": "No",
  "Q10.1": "Diagnostic",
  "Q11": "Not specified",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Not listed",
  "Q15": "No",
  "Q16": "No",
  "Q17": "The policy requires: 1) Completion of conventional diagnostic studies first (including history, physical examination, pedigree analysis) 2) Demonstration that the test will directly impact treatment 3) Documentation that the patient displays clinical features of the suspected condition or is at direct risk of inheriting the mutation 4) Meeting disease-specific criteria for the suspected diagnosis",
  "match": false
}